News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lynch Casey
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/26/2023 |
4
| Lynch Casey (Director) has filed a Form 4 on Longboard Pharmaceuticals, Inc.|
Txns:
| Granted 12,500 options to buy
@ $7.06, valued at
$88.3k
|
|
| 05/31/2022 |
4
| Lynch Casey (Director) has filed a Form 4 on Longboard Pharmaceuticals, Inc.|
Txns:
| Granted 12,367 options to buy
@ $4.4, valued at
$54.4k
|
|
| 01/05/2022 |
4
| Lynch Casey (CEO) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Granted 440,000 options to buy
@ $13.39, valued at
$5.9M
|
|
| 11/19/2021 |
4
| Lynch Casey (CEO) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Exercised 60,000 options to buy
@ $0.46, valued at
$27.6k
|
|
| 05/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2021 |
4
| Lynch Casey (Director) has filed a Form 4 on Longboard Pharmaceuticals, Inc.|
Txns:
| Granted 12,367 options to buy
@ $16, valued at
$197.9k
Granted 14,428 options to buy
@ $16, valued at
$230.8k
|
|
| 03/11/2021 |
3
| Lynch Casey (Director) has filed a Form 3 on Longboard Pharmaceuticals, Inc. |
| 02/03/2021 |
4
| Lynch Casey (CEO) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Sold 4,686 shares
@ $34.6, valued at
$162.1k
Sold 3,100 shares
@ $35.59, valued at
$110.3k
Sold 7,460 shares
@ $36.56, valued at
$272.7k
Sold 4,283 shares
@ $37.68, valued at
$161.4k
Sold 100 shares
@ $38.28, valued at
$3.8k
Sold 371 shares
@ $39.23, valued at
$14.6k
Sold 14,929 shares
@ $36.02, valued at
$537.7k
Sold 5,071 shares
@ $36.75, valued at
$186.4k
Sold 400 shares
@ $37.39, valued at
$15k
Sold 1,600 shares
@ $38.64, valued at
$61.8k
Sold 856 shares
@ $39.82, valued at
$34.1k
|
|
| 12/15/2020 |
4
| Lynch Casey (CEO) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Granted 175,000 options to buy
@ $29.6, valued at
$5.2M
|
|
| 02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/08/2019 |
3
| Lynch Casey (CEO) has filed a Form 3 on Cortexyme, Inc. |
|
|